DTC vs MRKR
DTC (DTC) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
DTC (DTC) common stock.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
DTC does not have a complete income-statement cache yet.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
MRKR currently screens at market cap $25.3M.
Not investment advice. Open the DTC and MRKR stock pages for the full models.
Not investment advice.